Back to search

Article

Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)

2020-08-14

Abstract excerpt

<title>Abstract</title> <p>Background Extracorporeal blood purification has been proposed as one of the therapeutic approaches in patients with coronavirus infection, because of its beneficial impact on elimination of inflammatory cytokines. Methods This controlled trial has been conducted on critically ill COVID-19 patients admitted in the state hospital affiliated to Babol University of Medical Sciences, Ira...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ef1b626-36e1-57c3-964a-e54974874856
DOI
10.21203/rs.3.rs-29229/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)DOI 10.21203/rs.3.rs-29229/v3
Efficacy and safety of convalescent plasma therapy for severe COVID-19 patients：case series study and literature reviewSemantic proximity
Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)Semantic proximity
Successful Treatment of Convalescent Plasma Therapy in Three Patients With Severe SARS-CoV-2 Infection in Fuzhou, ChinaSemantic proximity
Reviving the Critically Ill: Exploring Effective Fluid Resuscitation Approaches for Diverse Hypovolemic Shock Cases – A Systematic Review and Meta-AnalysisSemantic proximity
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19Semantic proximity
Treatment of COVID-19 Patients with Convalescent Plasma in Houston, TexasSemantic proximity
Low Molecular Weight Heparin Protects Lung, Renal and Microcirculation Function&nbsp;in Patients with Covid-19 PneumoniaSemantic proximity
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?Semantic proximity
Red Blood Cells Pathology in Patients with Coronavirus Disease 2019 (COVID-19)Semantic proximity
Randomised Clinical Trial to Evaluate Safety and Efficacy of Convalescent Plasma Use Among Hospitalized Patients with COVID-19 (PERUCONPLASMA): A Structured Summary af a Study Protocol for a Randomised Controlled Trial.Semantic proximity
Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19Semantic proximity
Are patients on chronic hemodialysis treatment protected against mortality due to COVID-19? A single-center retrospective cohort of patients hospitalized with COVID-19 requiring hemodialysis treatmentSemantic proximity
Select a neighboring publication to make it the new centre.